Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide as Add-on to Insulin in Type 1 Diabetes
NCT02092896Phase 3Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Mar 2013
- Primary completion
- Oct 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Copenhagen University Hospital - Hvidovre. Started Mar 2013; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02092896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092896.